5Behrla-Miellet J,Dubreuif.L,Umas-Bifak E.Antanaaerobic activity of moxifloxacin compared with that of ofloxacin,ciproflocaxin,clidamycin,met ronidazole and betalactams.Int J Antimicrob Agents,2002,20 (5):366-374.
二级参考文献38
1[1]Marston BJ,Plouffe JF,File TM, et al. Incidence of communityacquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med, 1997,157: 1709-1718.
2[2]Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol, 1993,137:977-988.
3[3]Gross PA, Rapuano C, Adrignolo A, et al. Nosocomial infections: decade-specific risk. Infect Control, 1983,4:145.
4[4]Marrie TJ, Blanchard W. A comparison of nursing homeacquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc, 1997,45:50-55.
5[5]Marrie TJ, Pneumonia in the elderly. Curr Opin Clin Med,1996,2: 192-197.
6[6]Granton JT, Grossman RF. Community-acquired pneumonia in the elderly patient: clinical features, epidemiology, and treatment. Clin Chest Med, 1993,14:537.
7[7]Woodhead M. Pneumonia in the elderly. J Antimicrob Chem other, 1994,34(Suppl ): 85-92.
8[8]Lieberman D, Lieberman D, Schlaeffer F, et al. Communityacquired pneumonia in old age: a prospective study of 91patients admitted from home. Age Ageing, 1997,26:69-75.
9[9]Fein AM, Feinsilver SH, Niederman MS. Atypical manifestations of pneumonia in the elderly. Clin Chest Med,1991,12:319.
10[10]Garb JL, Brown RB, Garb JR, et al. Differences in etiology of pneumonias in nursing home and community patients. JAMA,1978, 240:2169-2172.
